---
schema_version: "secwatch.filing_event.v1"
accession: "0001356576-24-000069"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:10:55.532205+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Supernus updates Code of Ethics and Business Conduct on Dec 19, 2024

## Summary
- Board of Directors approved an updated Code of Ethics and Business Conduct on December 19, 2024.
- Updates clarify reporting channels, consequences for violations, conflicts of interest, and compliance guidance.
- No waivers or implicit waivers were granted; code will be posted on the Investor Relations website.

## SEC filing metadata
- accession: 0001356576-24-000069
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000135657624000069/0001356576-24-000069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000135657624000069/supn-20241219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001356576-24-000069
- JSON: https://secwatch.observer/filing/0001356576-24-000069.json
- Plain text: https://secwatch.observer/filing/0001356576-24-000069.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.